| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |